• Health & Medicine

The HOPON clinical trial: a patient’s view

In the final post in our series about the HOPON clinical trial, we hear from a patient who recently took part in the research, Gerard Dean. In the final post in our series about the HOPON clinical trial, we hear from a patient who recently took part in the research, Gerard Dean.

9 January 2015

• Health & Medicine

The HOPON clinical trial: the research nurses’ role

In the second installment of our series on the HOPON clinical trial we hear from the research nurses who help to run the trial in Liverpool. In the second installment of our series on the HOPON clinical trial we hear from the research nurses who help to run the trial in Liverpool.

8 January 2015

• Health & Medicine

The HOPON clinical trial: the doctor’s perspective

In the first of a three-part series we hear from a doctor whose clinical trial was funded by Stand Up To Cancer in 2012. In the first of a three-part series we hear from a doctor whose clinical trial was funded by Stand Up To Cancer in 2012.

7 January 2015

• Health & Medicine

More than a third of people with abnormal results drop out of bowel cancer screening

Almost 40 per cent of people who have abnormal results from bowel cancer screening tests ignore their next screening invitation two years later. Almost 40 per cent of people who have abnormal results from bowel cancer screening tests ignore their next screening invitation two years later.

7 January 2015

Scientists zero in on how lung cancer spreads

Cancer Research UK scientists have taken microscopic images revealing that the protein ties tethering cells together are severed in lung cancer cells. Cancer Research UK scientists have taken microscopic images revealing that the protein ties tethering cells together are severed in lung cancer cells.

24 December 2014

• Health & Medicine

Cancer Research UK, Cancer Research Technology and Amgen to trial leukaemia immunotherapy drug in other cancers

Cancer Research UK, Cancer Research Technology and Amgen to trial leukaemia immunotherapy drug in patients with soild tuimours. Cancer Research UK, Cancer Research Technology and Amgen to trial leukaemia immunotherapy drug in patients with soild tuimours.

23 December 2014

Scientists map out how childhood brain tumours relapse

Researchers have discovered the unique genetic paths that the childhood brain tumour medulloblastoma follows when the disease comes back Researchers have discovered the unique genetic paths that the childhood brain tumour medulloblastoma follows when the disease comes back

18 December 2014

• Science & Technology

Combining images and genetic data proves gene loss behind aggressive ovarian cancers

Scientists have shown that loss of a gene called PTEN  triggers some cases of an aggressive form of ovarian cancer. Scientists have shown that loss of a gene called PTEN  triggers some cases of an aggressive form of ovarian cancer.

17 December 2014

• Health & Medicine

People with low numeracy feel negative about taking part in bowel cancer screening

People who have problems with numbers may be more likely to feel negative about bowel cancer screening. People who have problems with numbers may be more likely to feel negative about bowel cancer screening.

15 December 2014

• Health & Medicine

Tamoxifen protects against breast cancer in long-term

The breast cancer drug tamoxifen has been shown to protect against the disease for at least 20 years in women who take the drug for five years. The breast cancer drug tamoxifen has been shown to protect against the disease for at least 20 years in women who take the drug for five years.

11 December 2014

Three new companies join Cancer Research UK-Abcodia collaboration to identify blood markers for early cancer detection

Three new biomarker companies have been selected to join a CRT-lead initiative to develop blood tests that can detect pre-symotomatic cancer. Three new biomarker companies have been selected to join a CRT-lead initiative to develop blood tests that can detect pre-symotomatic cancer.

10 December 2014

Obese more likely to lose weight after cancer diagnosis

Obese cancer survivors are more likely to lose weight than those with a healthy weight and obese people without cancer. Obese cancer survivors are more likely to lose weight than those with a healthy weight and obese people without cancer.

9 December 2014